GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KYUNGNAM PHARM Co Ltd (XKRX:053950) » Definitions » Cyclically Adjusted PS Ratio

KYUNGNAM PHARM Co (XKRX:053950) Cyclically Adjusted PS Ratio : 0.28 (As of Jun. 01, 2025)


View and export this data going back to 2001. Start your Free Trial

What is KYUNGNAM PHARM Co Cyclically Adjusted PS Ratio?

As of today (2025-06-01), KYUNGNAM PHARM Co's current share price is ₩667.00. KYUNGNAM PHARM Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩2,395.13. KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio for today is 0.28.

The historical rank and industry rank for KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:053950' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.25   Med: 1.24   Max: 3.26
Current: 0.28

During the past years, KYUNGNAM PHARM Co's highest Cyclically Adjusted PS Ratio was 3.26. The lowest was 0.25. And the median was 1.24.

XKRX:053950's Cyclically Adjusted PS Ratio is ranked better than
91.87% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs XKRX:053950: 0.28

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

KYUNGNAM PHARM Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ₩175.409. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩2,395.13 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


KYUNGNAM PHARM Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KYUNGNAM PHARM Co Cyclically Adjusted PS Ratio Chart

KYUNGNAM PHARM Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.90 1.14 0.81 0.52 0.33

KYUNGNAM PHARM Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.33 0.32 0.33 0.25

Competitive Comparison of KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio falls into.


;
;

KYUNGNAM PHARM Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=667.00/2395.13
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KYUNGNAM PHARM Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, KYUNGNAM PHARM Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=175.409/122.5900*122.5900
=175.409

Current CPI (Mar. 2025) = 122.5900.

KYUNGNAM PHARM Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 696.147 100.051 852.974
201509 578.713 100.111 708.659
201512 577.284 100.220 706.136
201603 555.767 100.561 677.515
201606 608.730 100.791 740.388
201609 603.423 101.461 729.083
201612 775.737 101.561 936.357
201703 567.191 102.851 676.048
201706 681.850 102.611 814.608
201709 584.598 103.491 692.487
201712 660.981 102.991 786.766
201803 582.230 104.101 685.639
201806 758.069 104.130 892.456
201809 538.714 105.651 625.089
201812 642.587 104.351 754.904
201903 534.473 104.491 627.050
201906 535.863 104.881 626.343
201909 450.860 105.200 525.388
201912 495.790 105.121 578.179
202003 713.150 105.354 829.820
202006 653.772 105.112 762.483
202009 691.714 106.198 798.485
202012 773.328 105.765 896.345
202103 657.615 107.357 750.923
202106 568.075 107.579 647.344
202109 325.954 108.759 367.405
202112 411.303 109.676 459.731
202203 522.393 111.848 572.564
202206 413.866 114.072 444.769
202209 346.394 114.715 370.172
202212 368.922 115.179 392.659
202303 483.384 116.507 508.620
202306 332.815 117.182 348.174
202309 300.253 118.964 309.406
202312 344.231 118.837 355.102
202403 390.030 120.123 398.039
202406 279.204 120.007 285.213
202409 406.019 120.861 411.827
202412 227.958 121.135 230.696
202503 175.409 122.590 175.409

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


KYUNGNAM PHARM Co  (XKRX:053950) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


KYUNGNAM PHARM Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of KYUNGNAM PHARM Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


KYUNGNAM PHARM Co Business Description

Traded in Other Exchanges
N/A
Address
724-3 Wonsi-dong, Danwon-Gu, Ansan, Gyeonggi, KOR, 425-851
KYUNGNAM PHARM Co Ltd manufactures and markets medicines and health-aids foods.

KYUNGNAM PHARM Co Headlines

No Headlines